ArticlebioRxiv : the preprint server for biology2025
An intermediate activation state primes Langerhans cell migration from the epidermis.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Langerhans cells (LCs) are a specialized subset of dendritic cells in the epidermis, forming a dense network that acts as a frontline defense through immune surveillance. Upon antigen uptake, LCs become activated and orchestrate subsequent immune responses by migrating to lymphatics. However, how transcriptional programs are regulated during activation and how LCs behave in vivo during this transition remain poorly understood. Here, we combine single-cell transcriptomic analysis and intravital imaging to reconstruct the activation trajectory of epidermal LCs. We present a high-resolution single-cell transcriptomic dataset of over 22,000 high-quality epidermal LCs in both homeostatic and injured conditions. We define specific LC subpopulations representing sequential activation stages, characterized at the level of pathways and transcription factors. Notably, we identify a distinct intermediate state that precedes their migration. Integrating our data with an external dataset from homeostatic and injured skin reveals that wound-specific, WNT-modulated fibroblasts are the primary source of C3, the central component of the complement cascade. Intravital imaging of C3-deficient mice demonstrated that C3 is essential for effective recruitment of activated LCs to wound sites. Together, our findings uncover a novel population of activated epidermal LCs and highlight complement signaling as a critical mediator of LC recruitment during skin injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.